Precautions for discontinuing rasagiline
Rasagiline, as an effective drug for the treatment of Parkinson's disease, requires special attention during its use and discontinuation to ensure the safety and health of patients.
Before stopping using rasagiline, it is best to gradually reduce the dose of the drug under the guidance of your doctor. Stopping medication suddenly may cause adverse reactions in the body or even worsen the condition. Therefore, patients should follow the doctor's advice and slowly reduce the dosage of medication to allow the body to gradually adapt to the drug-free state.
During the withdrawal process, patients should closely monitor their body's reactions. If you experience any discomfort, such as dizziness, nausea, vomiting, insomnia and other symptoms, you should seek medical treatment in time and inform the doctor that you are discontinuing medication. The doctor will adjust the discontinuation plan or provide necessary treatment according to the patient's specific situation.
During the discontinuation period, patients should avoid drugs that interact with rasagiline, especially fluoxetine and fluvoxamine. These drugs may cause serious side effects when used together with rasagiline. Therefore, if you need to use other drugs during the discontinuation period, it is best to consult your doctor first.
During the withdrawal period, patients should maintain good living habits, including adequate sleep, a reasonable diet and appropriate exercise. These help reduce the discomfort of drug withdrawal and promote recovery.
After stopping the medication, the patient should go to the hospital for regular follow-up visits so that the doctor can understand the patient's physical condition in a timely manner and give necessary guidance and suggestions. Follow-up visits can help patients detect and deal with any potential health problems in a timely manner.
In addition, for specific groups of people, such as pregnant women, lactating women, children and the elderly, they should be more cautious and consult a doctor before stopping the drug. Especially pregnant and lactating women should fully understand the possible effects of the drug on the fetus or infant before using and discontinuing rasagiline.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)